Shumlin jabs controversial drugmaker but holds off full punch
BURLINGTON — Gov. Peter Shumlin walked a fine line Thursday on controversial drugmaker Mylan — which has recently become the object of derision for the soaring price of its EpiPen — condemning its pricing practices but praising its role as a Vermont employer.
EpiPen is an injection containing epinephrine, which can reopen airways following an allergic reaction. Health Commissioner Dr. Harry Chen described it as a lifesaving drug.
Mylan, maker of the EpiPen, has come under intensifying scrutiny from Congress as its list price has jumped from $100 in 2007 to $600 currently, according to The New York Times.
Mylan CEO Heather Bresch has become America’s latest “pharmaceutical villain,” the Times reported.
Read more: http://vtdigger.org/2016/08/26/shumlin-jabs-controversial-drugmaker-but-holds-off-full-punch/